
Molnupiravir supplies dominate in times of Paxlovid scarcity
While the US government is committed to buying 20m Paxlovid doses, deliveries have been slow compared to Merck’s molnupiravir.
ByFollow @ajhillman_ddj
Andrew Hillman is a data journalist at GlobalData Media, specialising in healthcare and pharmaceutical coverage. He is a graduate of Birmingham City University's data journalism program and previously worked as an analyst and modeller in the emergency healthcare sector.
While the US government is committed to buying 20m Paxlovid doses, deliveries have been slow compared to Merck’s molnupiravir.
By Andrew Hillman and Manasi VaidyaAn analysis of the demand for Covid-19 therapeutics allocation has shown that supply dynamics evolve slower than infection rates.
By Manasi Vaidya and Andrew HillmanInternet of things mentions have increased 280% in the filings of companies in the pharmaceutical industry since 2016
By Andrew HillmanAn analysis of FDA data shows the majority of drugs in short supply in the US are anaesthetics.
By Darcy Jimenez and Andrew HillmanOf the 50 biggest employers in pharma, Lonza Group referred to industrial automation the most between July 2020 and…
By Andrew HillmanHealthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the…
By Andrew HillmanThe frequency of sentences related to robotics between July 2020 and June 2021 was 50% higher than in 2016.
By Andrew HillmanLupin Ltd was the company that referred to artificial intelligence the most between July 2020 and June 2021.
By Andrew Hillman